MMR: patient group direction (PGD) template

PGD template to support the national MMR vaccination programme.


MMR: patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This patient group direction (PGD) template supports the administration of measles, mumps and rubella (MMR) vaccine, to individuals from 1 year of age for routine immunisation or from 6 months of age if early protection is required, in accordance with the national immunisation programme and PHE guidelines on post-exposure prophylaxis for measles. It is valid from 1 March 2018 to 29 February 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 24 March 2016
Last updated 21 February 2018 + show all updates
  1. Routine PGD update on expiry of v01.00.
  2. First published.